The Advanced Cell and Gene Therapy Workshop 2026 will be held in Naples, Italy, from June 8–12, bringing together leading experts and professionals at the forefront of therapeutic innovation. The program offers a comprehensive exploration of cutting-edge strategies in gene and cell therapy, covering key areas such as genome editing, delivery technologies, protein and gRNA design, and safety assessment.
Participants will gain in-depth insights into emerging therapeutic modalities, including antisense oligonucleotides (ASOs), non-coding RNA, and CAR-T cell therapies. The workshop also addresses critical components of the development pipeline, from advanced sequencing technologies to clinical translation and trial design.
Designed to foster meaningful dialogue between research and real-world application, the workshop features contributions from distinguished speakers across academia and industry, including representatives from AstraZeneca, GenScript, Miltenyi, Illumina, Aldevron, the University of Freiburg, and the University of Naples Federico II.
In addition to the scientific program, the Advanced Cell and Gene Therapy Workshop 2026 will provide multiple opportunities for exchange between participants and speakers. Coffee breaks and lunches will extend daily discussions, fostering interaction in an informal setting. Participants are welcome to present posters, sharing their work with speakers and fellow attendees. A guided tour scheduled for Wednesday afternoon will round out the program, offering further opportunities for networking and informal engagement.